1. Home
  2. ETD vs DCTH Comparison

ETD vs DCTH Comparison

Compare ETD & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ethan Allen Interiors Inc.

ETD

Ethan Allen Interiors Inc.

N/A

Current Price

$21.90

Market Cap

569.7M

ML Signal

N/A

DCTH

Delcath Systems Inc.

N/A

Current Price

$15.98

Market Cap

578.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ETD
DCTH
Founded
1932
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
569.7M
578.4M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
ETD
DCTH
Price
$21.90
$15.98
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$27.00
$22.00
AVG Volume (30 Days)
639.2K
367.8K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
8.15%
N/A
EPS Growth
N/A
107.53
EPS
1.56
0.04
Revenue
$766,784,000.00
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
$2.73
$33.15
P/E Ratio
$14.06
$397.75
Revenue Growth
N/A
N/A
52 Week Low
$18.28
$8.12
52 Week High
$30.11
$17.42

Technical Indicators

Market Signals
Indicator
ETD
DCTH
Relative Strength Index (RSI) 42.10 51.15
Support Level $21.10 $9.98
Resistance Level $22.79 $17.42
Average True Range (ATR) 0.61 0.39
MACD -0.22 -0.24
Stochastic Oscillator 20.00 15.75

Price Performance

Historical Comparison
ETD
DCTH

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: